IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.

RTTNews | 539 dagar sedan

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).

RTTNews | 722 dagar sedan

Australia Trims Key Interest Rate For Third Time This Year; Cuts Growth Outlook

The Reserve Bank of Australia reduced its benchmark interest rate by a quarter-point for the third time this year as underlying inflation continued to moderate, while economic growth outlook was lowered due to weaker-than-expected recovery in public demand. The board decided to trim the cash rate target by 25 basis points to 3.60 percent. The decision was unanimous.

RTTNews | 13 minuter sedan

European Shares Mostly Higher In Cautious Trade; Pound Climbs On Jobs Data

European stocks were broadly higher on Tuesday as the U.S. extended its pause on higher tariffs for Chinese goods until November 10, averting an immediate escalation in the trade war.

RTTNews | 33 minuter sedan

Australian Dollar Slides As RBA Cuts Key Interest Rate By 25 Bps

The Australian dollar weakened against other major currencies in the Asian session on Tuesday, after the Reserve Bank of Australia reduced its benchmark interest rate by a quarter-point as underlying inflation continued to soften and labor conditions eased slightly.

RTTNews | 35 minuter sedan